Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.675 USD | -0.37% | -3.68% | +26.66% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 543M | Sales 2025 * | 575M | Capitalization | 428M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 8M | EV / Sales 2024 * | 1.39 x |
Net Debt 2024 * | 328M | Net Debt 2025 * | 276M | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
-83.1
x | P/E ratio 2025 * |
92.2
x | Employees | 995 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.13% |
Latest transcript on Bioventus Inc.
1 day | -0.37% | ||
1 week | -3.68% | ||
Current month | -0.22% | ||
1 month | +68.14% | ||
3 months | +35.67% | ||
6 months | +51.36% | ||
Current year | +26.66% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Claypoole
CEO | Chief Executive Officer | 52 | Jan. 09 |
Mark Singleton
DFI | Director of Finance/CFO | 55 | 22-03-20 |
Katrina Church
CMP | Compliance Officer | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
CHM | Chairman | 70 | 16-06-29 |
Guy Nohra
BRD | Director/Board Member | 63 | 19-12-31 |
Martin Sutter
BRD | Director/Board Member | 69 | 16-06-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +8.96% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 6.7 | 0.00% | 312,061 |
24-06-03 | 6.7 | +0.15% | 373,512 |
24-05-31 | 6.69 | -1.33% | 287,990 |
24-05-30 | 6.78 | -0.44% | 270,359 |
24-05-29 | 6.81 | -1.73% | 273,511 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.66% | 428M | |
+75.69% | 12.57B | |
-24.12% | 7.29B | |
+10.90% | 6.81B | |
+20.88% | 5.67B | |
-16.83% | 4.91B | |
+19.43% | 4.18B | |
-20.45% | 3.86B | |
-24.00% | 2.92B | |
+52.88% | 2.57B |
- Stock Market
- Equities
- BVS Stock